Horizon Finance (HRZN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
A Special Meeting of Stockholders is scheduled for February 21, 2025, to approve a new investment management agreement due to a change in control of the investment adviser following Wendel SE's acquisition of a 75% equity interest in Monroe Capital, the adviser's parent.
The new agreement is identical in all material respects to the current agreement, with no changes to management, investment strategy, fee structure, or services provided.
The Board, including all Independent Directors, unanimously recommends voting in favor, citing continuity and anticipated benefits from Wendel's platform.
The transaction is expected to close in the first quarter of 2025, pending regulatory and shareholder approvals.
Voting matters and shareholder proposals
The sole proposal is to approve the new investment management agreement between the company and its adviser.
Approval requires the affirmative vote of the lesser of 67% of shares present or more than 50% of outstanding shares.
If not approved, the current agreement remains in effect; if the change in control occurs first, an interim agreement may be used for up to 150 days.
No other business is expected at the meeting, apart from possible adjournment for further proxy solicitation.
Board of directors and corporate governance
Six of eight board members are independent and will remain so after the change in control.
The Board reviewed comparative data, performance metrics, and peer benchmarks, concluding the agreement is fair and reasonable.
The Board will ensure at least 75% independence for three years post-transaction, in line with regulatory requirements.
Latest events from Horizon Finance
- Supplemental distributions proposed to enhance shareholder value amid merger approval process.HRZN
Proxy Filing11 Mar 2026 - Portfolio growth resumed in Q4, with strong yields and a transformative merger ahead.HRZN
Q4 20254 Mar 2026 - Merger creates a $446M NAV BDC, delivering a 33% NAV premium and scale benefits.HRZN
Q2 20253 Feb 2026 - NII and NAV fell, but 15.9% yield and strong liquidity support H2 2024 growth outlook.HRZN
Q2 20242 Feb 2026 - Net investment income fell, but portfolio growth and strong liquidity supported distributions.HRZN
Q3 202417 Jan 2026 - NII covered distributions in 2024, but NAV fell; strong yield and liquidity support 2025 growth.HRZN
Q4 202425 Dec 2025 - Vote sought on new investment management agreement; Board recommends approval for continuity.HRZN
Proxy Filing1 Dec 2025 - Shareholders will vote on director elections and auditor ratification, with robust governance in place.HRZN
Proxy Filing1 Dec 2025 - Vote on a new investment management agreement is urged following a change in adviser control.HRZN
Proxy Filing1 Dec 2025